BioNJ Board of Trustees Host Committee

 

Chairman

Francois Nader, M.D.
President and Chief Executive Officer
NPS Pharmaceuticals, Inc.

Immediate Past Chair

Sol J. Barer, Ph.D.
Former Chairman
Celgene Corporation

President and CEO

Debbie Hart
President and CEO
BioNJ

Vice Chairman

Christopher J. Schaber, Ph.D.
President and Chief Executive Officer
Soligenix, Inc.

Secretary

Donna Tempel, Ph.D., MBA
President and Chief Executive Officer
Drais Pharmaceuticals Inc.

Treasurer

Elizabeth G. Posillico, Ph.D.
President and Chief Executive Officer
Elusys Therapeutics, Inc.

Board Members

Al Altomari
President and Chief Executive Officer
Agile Therapeutics

Marc Bonnefoi, DVM, Ph.D.
Head of the North America R&D Hub and Vice President of Disposition, Safety and Animal Research Core Platform
Sanofi

John F. Crowley
Chairman and Chief Executive Officer
Amicus Therapeutics, Inc.

John Haney
Vice President, Immunology Marketing
Johnson & Johnson/Janssen Biotech

Christian Kopfli, Esq.
Chief Executive Officer
Chromocell Corporation

Will Lewis
President and Chief Executive Officer
Insmed Incorporated

John Maki
President and Chief Executive Officer
Vicus Therapeutics

Anthony S. Marucci, MBA
Founder, President, Chief Executive Officer and Director
Celldex Therapeutics, Inc.

Oye Olukotun, M.D., MPH, FACC, FAHA
Chief Executive Officer
CardioVax Inc.

Stuart W. Peltz, Ph.D.
Chief Executive Officer
PTC Therapeutics, Inc.

Spiro Rombotis
President and Chief Executive Officer
Cyclacel Pharmaceuticals, Inc.

Shawn Tomasello
Corporate Vice President and General Manager, US Hematology and Oncology
Celgene Corporation